Incyte
INCY
#1110
Rank
HK$156.68 B
Marketcap
HK$798.08
Share price
2.05%
Change (1 day)
36.89%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2025 (TTM): HK$47.75

According to Incyte's latest financial reports the company's current EPS (TTM) is HK$47.64. In 2024 the company made an earnings per share (EPS) of HK$2.41 a decrease over its 2023 EPS that were of HK$20.78.

EPS history for Incyte from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$47.751878.53%
2024HK$2.41-88.39%
2023HK$20.7873.38%
2022HK$11.99-64.1%
2021HK$33.40-408.63%
2020-HK$10.82-166.83%
2019HK$16.19300%
2018HK$4.05-133.33%
2017-HK$12.14-378.57%
2016HK$4.362700%
2015HK$0.16-106.67%
2014-HK$2.34-44.44%
2013-HK$4.2050%
2012-HK$2.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
HK$101.43 112.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$18.61-60.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$159.73 235.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.39-71.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-HK$0.93-101.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-HK$1.79-103.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.29 20.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
-HK$6.54-113.73%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-HK$4.52-109.48%๐Ÿ‡บ๐Ÿ‡ธ USA